Charles Wagner

CFO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VRTX

Current role

CFO

10 calls Latest call 2025-11-03

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Operating and Financial Officer	$974,808	—	$5,250,817	—	$1,965,000	$51,184	$8,241,809
2024	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$876,443	—	$5,250,328	—	$1,821,150	$51,519	$7,999,440
2023	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$825,000	—	$5,250,552	—	$1,256,063	$40,136	$7,371,751
2022	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$793,269	—	$3,750,197	—	$1,239,315	$28,830	$5,811,611
2021	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$729,615	—	$4,375,430	—	$1,078,539	$40,348	$6,223,932
2020	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$726,923	—	$4,375,585	—	$946,680	$41,202	$6,090,390
2019	Vertex Pharmaceuticals Inc / Ma (VRTX)	EVP & Chief Financial Officer	$492,692	$140,000	$1,225,383	$600,039	$992,250	$36,849	$3,487,213

Earnings-call appearances and filed executive appointments or departures, newest first.